123
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Visceral fat is associated with cirrhotic portal vein thrombosis

, , , , , , , & show all
Pages 1017-1022 | Received 08 Apr 2019, Accepted 31 Jul 2019, Published online: 08 Aug 2019

References

  • Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000 May 15;69(9):1873–1881.
  • Qi X, Guo X, Han G. Risk stratification in the management of portal vein thrombosis in cirrhosis. J Gastrointestin Liver Dis. 2016 Mar;25(1):119–120.
  • Sarin SK, Philips CA, Kamath PS, et al. Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis. Gastroenterology. 2016 Oct;151(4):574–577 e3.
  • European Association for the Study of the Liver. Electronic address eee. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016 Jan;64(1):179–202.
  • Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005 May;54(5):691–697.
  • Turon F, Hernandez-Gea V, Garcia-Pagan JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Curr Opin Organ Transplant. 2018 Apr;23(2):250-256. doi: 10.1097/MOT.0000000000000506.
  • Fimognari FL, Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med. 2008 Sep;3(3):213–218.
  • Tsochatzis EA, Senzolo M, Germani G, et al. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010 Feb 1;31(3):366–374.
  • Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009 Oct;51(4):682–689.
  • Nery F, Chevret S, Condat B, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology. 2015 Feb;61(2):660–667.
  • Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol. 2007 May 14;13(18):2535–2540.
  • Qi X, Li H, Liu X, et al. Novel insights into the development of portal vein thrombosis in cirrhosis patients. Expert Rev Gastroenterol Hepatol. 2015;9(11):1421–1432.
  • Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen city heart study. Circulation. 2010 May 4; 121(17):1896–1903.
  • Kwasny C, Manuwald U, Kugler J, et al. Systematic review of the epidemiology and natural history of the metabolic vascular syndrome and its coincidence with type 2 diabetes mellitus and cardiovascular diseases in different European Countries. Horm Metab Res. 2018 Mar;50(3):201-208. doi: 10.1055/s-0043-122395.
  • Aranceta-Bartrina J, Perez-Rodrigo C, Alberdi-Aresti G, et al. Prevalence of general obesity and abdominal obesity in the Spanish adult population (Aged 25–64 Years) 2014–2015: the ENPE study. Rev Esp Cardiol (Engl Ed). 2016 Jun;69(6):579–587.
  • Hernaez A, Zomeno MD, Degano IR, et al. Excess weight in spain: current situation, projections for 2030, and estimated direct extra cost for the Spanish health system. Rev Esp Cardiol (Engl Ed). 2018 Nov 23. pii: S1885-5857(18)30440-7. doi: 10.1016/j.rec.2018.10.010. [Epub ahead of print].
  • Kok B, Karvellas CJ, Abraldes JG, et al. The impact of obesity in cirrhotic patients with septic shock: a retrospective cohort study. Liver Int. 2018 Jul;38(7):1230-1241. doi: 10.1111/liv.13648.
  • Liu B, Balkwill A, Reeves G, et al. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ. 2010 Mar;11(340):c912.
  • Ayala R, Grande S, Bustelos R, et al. Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol. 2012 Aug;21(12):114.
  • Severinsen MT, Kristensen SR, Johnsen SP, et al. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation. 2009 Nov 10;120(19):1850–1857.
  • Borch KH, Braekkan SK, Mathiesen EB, et al. Anthropometric measures of obesity and risk of venous thromboembolism: the tromso study. Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):121–127.
  • Bureau C, Laurent J, Robic MA, et al. Central obesity is associated with non-cirrhotic portal vein thrombosis. J Hepatol. 2016 Feb;64(2):427–432.
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA. 2001 May 16;285(19):2486–2497.
  • Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995 Jul 15;311(6998):158–161.
  • Okosun IS, Chandra KM, Boev A, et al. Abdominal adiposity in U.S. adults: prevalence and trends, 1960–2000. Prev Med. 2004 Jul;39(1):197–206.
  • Bartell N, Al-Judaibi B. The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: more questions on the horizon. Saudi J Gastroenterol. 2018 Jan-Feb;24(1):3–4.
  • Violi F, Corazza GR, Caldwell SH, et al. Portal vein thrombosis relevance on liver cirrhosis: Italian venous thrombotic events registry. Intern Emerg Med. 2016 Dec;11(8):1059–1066.
  • Xu X, Guo X, De Stefano V, et al. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Hepatol Int. 2019;13(4):468-481.
  • van der Kooy K, Leenen R, Seidell JC, et al. Effect of a weight cycle on visceral fat accumulation. Am J Clin Nutr. 1993 Dec;58(6):853–857.
  • Darvall KA, Sam RC, Silverman SH, et al. Obesity and thrombosis. Eur J Vasc Endovasc Surg. 2007 Feb;33(2):223–233.
  • Allman-Farinelli MA. Obesity and venous thrombosis: a review. Semin Thromb Hemost. 2011 Nov;37(8):903–907.
  • Sugerman H, Windsor A, Bessos M, et al. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med. 1997 Jan;241(1):71–79.
  • Tripodi A, Fracanzani AL, Primignani M, et al. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. J Hepatol. 2014 Jul;61(1):148–154.
  • Kotronen A, Joutsi-Korhonen L, Sevastianova K, et al. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. Liver Int. 2011 Feb;31(2):176–183.
  • Pirlich M, Schutz T, Spachos T, et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology. 2000 Dec;32(6):1208–1215.
  • Bohm D, Odaischi M, Beyerlein C, et al. Total body water: changes during dialysis estimated by bioimpedance analysis. Infusionstherapie. 1990 Apr;17(Suppl 3):75–78.
  • Anderson LJ, Erceg DN, Schroeder ET. Utility of multifrequency bioelectrical impedance compared with dual-energy x-ray absorptiometry for assessment of total and regional body composition varies between men and women. Nutr Res. 2012 Jul;32(7):479–485.
  • Ogawa H, Fujitani K, Tsujinaka T, et al. InBody 720 as a new method of evaluating visceral obesity. Hepatogastroenterology. 2011 Jan-Feb;58(105):42–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.